Bovine Tuberculosis Diagnostic Market (2026 - 2033)

Bovine Tuberculosis Diagnostic Market Summery

The global bovine tuberculosis diagnostic market size was valued at USD 786.8 million in 2025 and is projected to grow from USD 819.9 million in 2026 to USD 1,073.2 million by 2033, at a CAGR of 4.2% from 2026 to 2033. Europe dominated the market, accounting for the largest revenue share of 35.5% in 2025. As governments and health organizations implement better control measures, the demand for reliable and rapid diagnostic tools has increased, driving market growth.

Key Market Trends & Insights

• By test: The traditional tests segment led the market with a revenue share of 59.5% in 2025.

Regional Highlights

• Largest regional market: Europe (35.5% revenue share, 2025)
• Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)

Market Size & Forecast

• Market size in 2025: USD 786.8 Million
• Estimated market size in 2026: USD 819.9 Million
• Projected market size by 2033: USD 1,073.2 Million
• CAGR (2026-2033): 4.2%

Bovine tuberculosis (TB) is a significant threat to the dairy and meat industries, which are critical components of the agricultural economy in many countries. Infected cattle often experience reduced milk production and lower meat quality, resulting in economic losses for farmers. The threat of Bovine tuberculosis outbreaks also leads to trade restrictions and a loss of consumer trust. For instance, in June 2026, the United Kingdom announced a new national bovine tuberculosis eradication strategy that includes the rollout of cattle vaccination programs, improved diagnostic testing systems, and enhanced disease surveillance frameworks to reduce annual cattle slaughter and economic losses in the livestock sector. The strategy emphasizes the importance of rapid detection and improved testing accuracy to control disease transmission and protect dairy and meat production systems, reinforcing the growing demand for advanced bovine tuberculosis diagnostic solutions. As a result, dairy and meat producers are increasingly investing in preventive measures, including regular testing and diagnosis of cattle, to safeguard their animals and ensure product quality, driving the bovine TB diagnosis market.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The expansion and modernization of veterinary healthcare infrastructure, particularly in developing regions, drive the bovine tuberculosis diagnosis market. Improved access to veterinary services and the establishment of specialized animal health clinics and laboratories enable more widespread and efficient disease diagnosis. As these infrastructures develop, the availability and adoption of advanced diagnostic tools are expected to increase, contributing to market growth.

Analyst Perspective

The bovine tuberculosis diagnosis market is witnessing steady growth due to the significant economic impact of bovine TB on the dairy and meat industries, including reduced milk production, lower meat quality, financial losses, trade restrictions, and declining consumer confidence. This is driving the adoption of routine screening and advanced diagnostic testing as governments strengthen disease surveillance and eradication programs. Advancements in molecular assays and rapid detection technologies are further supporting market growth by improving diagnostic accuracy and turnaround times. Developed regions such as Europe and North America lead the market due to strong veterinary infrastructure and stringent regulations, while emerging economies are expanding diagnostic capabilities to address growing livestock populations and zoonotic disease risks.

Test Insights

The traditional tests segment dominated the market, accounting for a share of 59.5% in 2025. Traditional bovine TB tests benefit from widespread availability and the established infrastructure required for their administration. Veterinary clinics, agricultural cooperatives, and government agencies in many regions are well equipped to perform tuberculin skin tests, ensuring easy access for farmers. The infrastructure for handling, storing, and administering these tests is already in place in many areas, reducing the need for additional investments in new equipment or training. This established infrastructure supports the continued demand for traditional diagnostic tests.

The molecular diagnostic tests segment is expected to witness the fastest CAGR over the forecast period. Molecular diagnostic tests offer significantly higher sensitivity and specificity. For instance, in March 2026, a veterinary diagnostic study highlighted the increasing use of molecular techniques, such as PCR-based assays, for detecting Mycobacterium bovis, enabling more accurate and earlier-stage identification of infection. These tests detect Mycobacterium bovis at the molecular level, enabling earlier and more accurate detection of the disease. This capability is essential when early diagnosis is crucial to prevent the spread of bovine tuberculosis within and between herds. The ability to provide more reliability drives the adoption of molecular diagnostic tests.

Regional Insights

Europe bovine tuberculosis diagnosis market led held the largest revenue share of 35.5% in 2025. The region's veterinary professionals and livestock producers have access to the latest diagnostic tools, including molecular diagnostics. The widespread adoption of these advanced technologies is driven by the more accurate, sensitive, and rapid detection of bovine tuberculosis, which is essential for effective disease management and control. The region's high level of awareness about bovine tuberculosis and the availability of advanced diagnostic technologies drives its demand in the market.

To learn more about this report, Download Free Sample Report

The UK bovine tuberculosis diagnosis market accounted for the largest revenue share in 2025. Bovine tuberculosis poses a severe threat to the productivity and profitability of livestock industries, making disease control a priority. The economic impact of bovine tuberculosis, including potential trade restrictions, loss of market access, and the costs associated with culling infected animals, drives the demand for reliable diagnostic testing. Producers regularly conduct tests on their herds to avoid outbreaks and maintain economic viability.

Asia Pacific Bovine Tuberculosis Diagnostic Market Trends

The Asia Pacific bovine tuberculosis diagnosis market is expected to witness the fastest CAGR over the forecast period. As the livestock industry expands to meet the increasing demand for meat and dairy products, the risk of disease outbreaks, including bovine tuberculosis, also increases. The need to ensure herd health and productivity drives the demand for effective diagnostic tools to identify and manage bovine tuberculosis. The region's large-scale and intensive livestock farming necessitates regular testing and surveillance, fueling the growth of the Bovine Tuberculosis Diagnosis market.

Bovine tuberculosis diagnosis market in Chinaaccounted for the largest revenue share in 2025. The beef and dairy sectors are economically significant in China, contributing to domestic consumption and exports. Maintaining disease-free is essential for the sustainability of these sectors, as outbreaks of bovine tuberculosis lead to substantial economic losses. The economic importance of these industries drives the demand for regular diagnostic testing to prevent and control the spread of bovine tuberculosis. Producers invest in diagnostic tools to avoid the financial problems of disease outbreaks, including potential culling of infected animals and loss of market access.

North America Bovine Tuberculosis Diagnostic Market Trends

The North America bovine tuberculosis diagnosis market is expected to witness significant growth over the forecast period. There is a growing focus on animal health and the prevention of zoonotic diseases in North America, driven by public health concerns and the potential impact on human health. Bovine tuberculosis is a zoonotic disease that is able to transmit from animals to humans, typically through unpasteurized dairy products or close contact with infected animals. The risk of zoonotic transmission has led to increased efforts to monitor and control bovine tuberculosis, driving the demand for reliable diagnostic tests.

U.S. Bovine Tuberculosis Diagnosis Market Trends

The U.S. bovine tuberculosis diagnosis market accounted for the largest revenue share in 2025. Veterinary schools and professional associations provide ongoing training on the latest diagnostic methods and biosecurity practices. This education ensures that veterinarians are well-equipped to implement the most effective testing protocols, contributing to the consistent use of traditional and modern diagnostic tools. The focus on education and training drives the market by ensuring that diagnostic methods are used effectively and widely.

Key Bovine Tuberculosis Diagnostic Company Insights

Some key companies in the bovine tuberculosis diagnosis market include IDEXX Laboratories, Inc., PBD Biotech Ltd, Thermo Fisher Scientific Inc., Bionote USA Inc., and others.

• IDEXX Laboratories, Inc. is a leading veterinary diagnostics, software, and water microbiology testing company. The company's product offerings include diagnostic instruments such as the Catalyst One and ProCyte Dx analyzers, which provide comprehensive blood chemistry, hematology, and immunoassay testing.

• PBD Biotech Ltd is a biotechnology company that develops innovative diagnostic solutions for infectious diseases. Its product is the Actiphage test, an advanced diagnostic tool that uses bacteriophage technology to detect mycobacteria, the bacterium responsible for bovine tuberculosis.

Key Bovine Tuberculosis Diagnostic Companies

The following key companies have been profiled for this study on the bovine tuberculosis (TB) diagnostic market:

• IDEXX Laboratories, Inc.

• PBD Biotech Ltd

• Zoetis Services LLC

• IDvet

• Thermo Fisher Scientific Inc.

• Enfer Group

• AsureQuality

• Bio-Rad Laboratories, Inc.

• Bionote USA Inc.

Global Bovine Tuberculosis Diagnostic Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global bovine tuberculosis diagnostic market report based on test, and region:

• Test Outlook (Revenue, USD Million, 2021 - 2033)
  • Serological Tests
  • Molecular Diagnostic Tests
  • Traditional Tests
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia